Sucralfate and Actigall drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sucralfate (sucralfate) and Actigall (ursodiol). Common drug interactions include nausea among females and dehydration among males.

The phase IV clinical study analyzes what interactions people have when they take Sucralfate and Actigall. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.

What is Actigall?

Actigall has active ingredients of ursodiol. It is often used in gallstones. eHealthMe is studying from 2,162 Actigall users. Check the latest studies of Actigall.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

16 people who take Sucralfate and Actigall together, and have interactions are studied.

Sucralfate and Actigall drug interactions.

What are the common drug interactions of Sucralfate and Actigall, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Weight increased
  3. Abdominal adhesions (inflammation of abdomen)
  4. Biliary cirrhosis (biliary cirrhosis occurs due to obstruction to the flow of bile through bile ducts either within the liver or outside the liver)
  5. Cerebral haematoma (collection of blood in brain)
  6. Cerebral haemorrhage (bleeding within the brain)
  7. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  8. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  9. Coagulopathy (blood's ability to clot is impaired)
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

male:

  1. Dehydration (dryness resulting from the removal of water)
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Chronic kidney disease
  4. Colitis haemorrhagic (bleeding diarrhoea due to infection of colon)
  5. Cytomegalovirus infection
  6. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  7. Dyspnoea (difficult or laboured respiration)
  8. Fatigue (feeling of tiredness)
  9. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  10. Fungal infection

What are the common drug interactions of Sucralfate and Actigall, by age (0-1 to 60+)? *:

0-1:

  1. Abdominal adhesions (inflammation of abdomen)
  2. Biliary cirrhosis (biliary cirrhosis occurs due to obstruction to the flow of bile through bile ducts either within the liver or outside the liver)
  3. Cerebral haematoma (collection of blood in brain)
  4. Cerebral haemorrhage (bleeding within the brain)
  5. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  6. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  7. Coagulopathy (blood's ability to clot is impaired)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Hypersensitivity
  10. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

2-9:

n/a

10-19:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  2. Pneumonia

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Oesophageal ulcer (ulcer of oesophagus)
  3. Oesophagitis (inflammation of oesophagus)
  4. Blood alkaline phosphatase nos increased
  5. Blood amylase decreased
  6. Dehydration (dryness resulting from the removal of water)
  7. Gastrointestinal motility disorder (abnormal intestinal contractions)
  8. Haematocrit decreased
  9. Haemoglobin abnormal
  10. International normalised ratio decreased

60+:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  6. Fungal infection
  7. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  8. Hepatic function abnormal
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

  1. Nervous System Disorder (a general class of medical conditions affecting the nervous system): 6 people, 37.50%
  2. Neoplasm Malignant (cancer tumour): 6 people, 37.50%
  3. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 12.50%
  4. Toxic Neuropathy (nerve damage caused by toxic (harmful) substances): 2 people, 12.50%
  5. Gastric Ulcer (stomach ulcer): 2 people, 12.50%
  6. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 6.25%
  7. Hallucinations (sensations that appear real but are created by your mind): 1 person, 6.25%
  8. Cough: 1 person, 6.25%
  9. Cystic Fibrosis (disease of the secretary glands): 1 person, 6.25%
  10. Delusion (a false belief or opinion): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Sucralfate and Actigall?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sucralfate and Actigall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sucralfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Actigall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sucralfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actigall and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sucralfate and ursodiol (the active ingredients of Sucralfate and Actigall, respectively), and Sucralfate and Actigall (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: